🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Christopher Massey

Cumbria Northumberland Tyne and Wear NHS Foundation Trust

ORCID: 0000-0002-2396-8909
MedicineEconomics, Econometrics and FinanceHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Supporting good quality, community-based end-of-life care for people living with dementia: the SEED research programme including feasibility RCT”.

Supporting good quality, community-based end-of-life care for people living with dementia: the SEED research programme including feasibility RCT

Programme Grants for Applied Research(2020)10.3310/pgfar08080
N/A
0DataRank · unranked
11 citations

Marie Poole, Emma McLellan, Richard Lee, Sarah Amador, Nawaraj Bhattarai +26 more

The Development of a Novel Nanobody Therapeutic for SARS-CoV-2

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.11.17.386532
N/A
0DataRank · unranked
25 citations

Joseph P. Gallant, Christopher Massey, Ke Shi, Wanbo Tai, Jian Zheng +14 more

Pyronaridine Tetraphosphate Efficacy Against Ebola Virus Infection in Guinea Pig

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.03.20.001081
N/A
0DataRank · unranked
4 citations

Christopher Massey, Jason E. Comer, Alexander N. Freiberg, Huanying Zhou, Julie Dyall +6 more

Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade

Science Translational Medicine(2021)10.1126/scitranslmed.abb3631
N/A
0DataRank · unranked
233 citations

Reinier Hernandez, Peter M. Carlson, Joseph J. Grudzinski, Amber M. Bates, Justin C. Jagodinsky +17 more

The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates

eLife(2021)10.7554/elife.64815
N/A
0DataRank · unranked
62 citations

Joseph P. Gallant, Jian Zheng, Christopher Massey, Ke Shi, Wanbo Tai +10 more

[68 Ga]Ga-FAPI-46 PET for non-invasive detection of pulmonary fibrosis disease activity

European Journal of Nuclear Medicine and Molecular Imaging(2022)10.1007/s00259-022-05814-9
N/A
0DataRank · unranked
112 citations

Christopher Massey, Ksenija Bernau, Carolina A. Ferreira, Justin J. Jeffery, Jefree J. Schulte +9 more

Antitumor efficacy of 90Y-NM600 targeted radionuclide therapy and PD-1 blockade is limited by regulatory T cells in murine prostate tumors

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-005060
N/A
0DataRank · unranked
32 citations

Carolina A. Ferreira, Joseph J. Grudzinski, Christopher Massey, Eduardo Aluicio‐Sarduy, Jonathan W. Engle +7 more

Profound immunomodulatory effects of 225 Ac-NM600 drive enhanced anti-tumor response in prostate cancer

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.09.26.509374
N/A
0DataRank · unranked
3 citations

Hemanth K. Potluri, Christopher Massey, Joseph J. Grudzinski, Amanda Carston, Nathan C. Clemons +12 more

UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas

Cell Reports Medicine(2024)10.1016/j.xcrm.2023.101381
N/A
0DataRank · unranked
31 citations

Timothy Chai, Fernando Jose Garcia-Marques, Qingqing Yin, En‐Chi Hsu, Michelle Shen +25 more